Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter
- 1 September 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (7) , 567-573
- https://doi.org/10.1016/0002-9149(93)90353-e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Redefining the role of digoxin in the treatment of atrial fibrillationThe American Journal of Cardiology, 1992
- A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter studyJournal of the American College of Cardiology, 1991
- Digoxin for Atrial Fibrillation: A Drug Whose Time Has Gone?Annals of Internal Medicine, 1991
- Failure of Long-term Digitalization to Prevent Rapid Ventricular Response in Patients with Paroxysmal Atrial FibrillationChest, 1991
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: Results of a multicenter, baseline-controlled safety and efficacy study in 160 patientsAmerican Heart Journal, 1986
- Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmiasAmerican Heart Journal, 1986
- Atrial Fibrillation and FlutterArchives of internal medicine (1960), 1983
- Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or FlutterAnnals of Internal Medicine, 1981